流感临床试验招募信息（全球在招）

这里汇总了全球正在招募患者的 流感（国际通用名 influenza）新药临床试验，包含试验分期、招募状态、开展国家和研究团队联系方式，全部以中文呈现。数据实时来自全球最大的临床试验注册库 ClinicalTrials.gov。本页同时覆盖流行性感冒等说法。

正在招募的流感新药试验

• Clinical Study on the Immune Response Characteristics of Novel Coronavirus and Influenza Virus Infection

  不适用招募中中国NCT06667063

• Safety and Pharmacokinetics of Ingavirin Forte, Capsules, 90 mg + 20 mg (Valenta Pharm JSC, Russia) Compared With Ingavirin, Capsules, 90 mg, Under Fasting and Fed Conditions.

  I 期招募中RussiaNCT07645534

• Surveillance, Assessment and Detection of Influenza Associated Respiratory Infections in HIV Positive and Negative Individual in Lusaka, Zambia.

  不适用招募中ZambiaNCT07030075

• Prostate Specific Membrane Antigen (PSMA) or (FACBC) PET/CT Site-Directed Therapy for Treatment of Prostate Cancer, Flu-BLAST-PC Study

  II 期招募中美国NCT04175431

• Administration of the Nasal Influenza Vaccine to Children in Daycare or at a Healthcare Facility

  不适用招募中FinlandNCT07310472

• Influenza Vaccination, ACEI and ARB in the Evolution of SARS-CoV2 Infection

  不适用招募中西班牙NCT04367883

• A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adults

  I 期招募中美国NCT07464314

• A Surveillance Study of Susceptibility to Baloxavir Marboxil in Pediatric Participants With Influenza and Transmission of Influenza to Household Contacts

  III 期招募中美国BulgariaPoland西班牙NCT06094010

• Adaptive Platform Trial of Treatments for Respiratory Infections in Community Settings (TreatResp)

  III 期招募中加拿大NCT07314905

• Efficacy of Baloxavir Against Influenza in Hospitalized Patients: The INFLUENT Study (INpatients inFLUENza Treatment)

  III 期招募中SwitzerlandNCT06653569

• The INFLUENTIAL Trial- Evaluation of National Inpatient Influenza Vaccination Program

  不适用招募中美国NCT05832307

• Baloxavir and Oseltamivir for the Treatment of Severe Influenza Infection in Immunocompromised Patients

  II 期招募中美国NCT04712539